These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 8301578

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. An orally active renin inhibitor: cyclohexylnorstatine-containing dipeptide (KRI-1314).
    Miyazaki M, Etoh Y, Iizuka K, Toda N.
    J Hypertens Suppl; 1989 Apr; 7(2):S25-7. PubMed ID: 2666609
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Antihypertensive activity of dl-15-deoxy-16-hydroxy-16(alpha/beta)-vinyl prostaglandin E2 methyl ester (CL 115,347), a new orally and transdermally long-acting antihypertensive agent.
    Chan PS, Cervoni P, Ronsberg MA, Accomando RC, Quirk GJ, Scully PA, Lipchuck LM.
    J Pharmacol Exp Ther; 1983 Sep; 226(3):726-32. PubMed ID: 6887009
    [Abstract] [Full Text] [Related]

  • 6. Renal hemodynamic and excretory responses to renin inhibition induced by A-64662.
    Verburg KM, Kleinert HD, Chekal MA, Kadam JR, Young GA.
    J Pharmacol Exp Ther; 1990 Feb; 252(2):449-55. PubMed ID: 2179529
    [Abstract] [Full Text] [Related]

  • 7. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
    Jackson EK, Dubinion JH, Mi Z.
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
    [Abstract] [Full Text] [Related]

  • 8. Effects of SC-56525, a potent, orally active renin inhibitor, in salt-depleted and renal hypertensive dogs.
    McMahon EG, Yang PC, Babler MA, Bittner SE, Suleymanov OD, Cain-Janicki KJ, Bedell LJ, Hanson GJ, Cook CS.
    Hypertension; 1995 Jul; 26(1):95-100. PubMed ID: 7607739
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The human renin infused rat: use as an in vivo model for the biological evaluation of human renin inhibitors.
    Bolger G, Vigeant JC, Liard F, Simoneau B, Thibeault D, Pilote L, Lamarre D, Jung G, Anderson P, Jaramillo J.
    Can J Physiol Pharmacol; 1999 Nov; 77(11):886-95. PubMed ID: 10593662
    [Abstract] [Full Text] [Related]

  • 11. Acute hypotensive responses to peptide inhibitors of renin in conscious monkeys: an effect on blood pressure independent of plasma renin inhibition.
    Schaffer LW, Schorn TW, Winquist RJ, Strouse JF, Payne L, Chakravarty PK, de Laszlo SE, tenBroeke J, Veber DF, Greenlee WJ.
    J Hypertens; 1990 Mar; 8(3):251-9. PubMed ID: 2159506
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A pharmacodynamic study of the renin inhibitor SR 43,845, administered intratracheally in conscious cynomolgus monkeys.
    Lacour C, Roccon A, Cazaubon C, Richaud JP, Segondy D, Nisato D.
    J Hypertens Suppl; 1991 Dec; 9(6):S384-5. PubMed ID: 1819002
    [No Abstract] [Full Text] [Related]

  • 14. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
    Jensen J, Henik RA, Brownfield M, Armstrong J.
    Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
    [Abstract] [Full Text] [Related]

  • 15. Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans.
    Fisher ND, Jan Danser AH, Nussberger J, Dole WP, Hollenberg NK.
    Circulation; 2008 Jun 24; 117(25):3199-205. PubMed ID: 18559696
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antihypertensive and natriuretic effects of CGS 30440, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase 24.11.
    Chatelain RE, Ghai RD, Trapani AJ, Odorico LM, Dardik BN, De Lombaert S, Lappe RW, Fink CA.
    J Pharmacol Exp Ther; 1998 Mar 24; 284(3):974-82. PubMed ID: 9495857
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.